The ancillary cannabis sector continues to attract attention as market conditions shift. The U.S. cannabis industry is expected to reach $45 billion in sales by 2025. Growth remains steady, with projections calling for double-digit annual gains through 2030. Ancillary companies benefit by supporting cultivators and retailers without touching the plant. They provide hydroponic systems, lighting,...
As the cannabis industry continues to prosper, most marijuana stocks have not. Yet, the progress and innovation in legal cannabis are nothing short of amazing. Just the battle in the United States alone has been an ongoing fight that still amazes many. Almost all of the United States has legalized cannabis in some form. The states that are left have a community of supporters working to get legi...
Ancillary cannabis stocks are drawing attention this week as the U.S. cannabis industry continues its rapid expansion. In 2024, the market reached $38.5 billion in total value. Analysts expect it to grow at an annual rate of over 11% through 2030. Sales from both medical and adult-use cannabis are projected to surge in 2025. Additionally, the total economic impact may exceed $120 billion this y...
The progress of the cannabis industry has been a remarkable achievement. Now many knew this explosion of legal cannabis would happen in such a way. Legal cannabis across the globe is growing and spreading like wildfire. Even though marijuana stocks are not seeing the same success as companies investing in the public sector, it could be profitable down the line. Companies have been expanding ope...
As most marijuana stocks are trading at all-time lows some are troubled by how a successful industry can be doing poorly in the market. As the 2025 first-quarter earnings show, a bulk of the companies that reported showed solid results. This ranges from new products and partnerships to increased profits and revenue. In addition to company growth and shortcomings as well. Overall the cannabis in...
The U.S. cannabis industry continues to expand, even with ongoing regulatory challenges. In 2025, the market is projected to generate over $45 billion in revenue. Consumer demand is rising, and dispensary numbers continue to grow across the country. By 2030, the market could exceed $75 billion, driven by both medical and recreational use. So far, 24 states and Washington, D.C., have legalized r...
Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM ) Q1 2025 Results Conference Call May 13, 2025 8:30 AM ET Company Participants Anna Kate Heller - ICR John Lindeman - Chief Executive Officer Kevin O'Brien - Chief Financial Officer Conference Call Participants Dmitry Silversteyn - Water Tower Research Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Hydrofarm Hol...
SHOEMAKERSVILLE, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its first quarter ended March 31, 2025.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.